D'Orazio & Associates »

Aurinia Pharmaceuticals shares owned by D'Orazio & Associates

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by D'Orazio & Associates from 13F filings

Historical chart of D'Orazio & Associates investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by D'Orazio & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by D'Orazio & Associates

Quarter filed Position value Share count Share price at filing
2026-06-30 $232k 14k 16.97

More positions owned by D'Orazio & Associates

Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Income Etf (JPIE)
Ishares Tr Msci Intl Qualty (IQLT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Usa Mmentm (MTUM)
UnitedHealth (UNH)
Invesco Exch Traded Fd Tr Ii S&p Intl Momnt (IDMO)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)

View all positions for D'Orazio & Associates

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Marshall Wace
Renaissance Technologies
D. E. Shaw & Co
Geode Capital Management
Goldman Sachs Group
Vanguard Portfolio Management
Jacobs Levy Equity Management
LSV Asset Management

View all funds holding Aurinia Pharmaceuticals